A detailed history of Ubs Group Ag transactions in Cardlytics, Inc. stock. As of the latest transaction made, Ubs Group Ag holds 47,147 shares of CDLX stock, worth $182,458. This represents 0.0% of its overall portfolio holdings.

Number of Shares
47,147
Previous 39,891 18.19%
Holding current value
$182,458
Previous $327,000 54.13%
% of portfolio
0.0%
Previous 0.0%

Shares

27 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$2.96 - $9.15 $21,477 - $66,392
7,256 Added 18.19%
47,147 $150,000
Q2 2024

Aug 13, 2024

SELL
$8.03 - $15.41 $311,804 - $598,370
-38,830 Reduced 49.33%
39,891 $327,000
Q1 2024

May 13, 2024

BUY
$5.77 - $20.25 $496 - $1,741
86 Added 0.11%
78,721 $1.14 Million
Q4 2023

Feb 09, 2024

BUY
$6.11 - $14.1 $185,469 - $428,005
30,355 Added 62.87%
78,635 $724,000
Q3 2023

Nov 09, 2023

BUY
$5.78 - $19.17 $41,731 - $138,407
7,220 Added 17.58%
48,280 $796,000
Q2 2023

Aug 11, 2023

BUY
$3.45 - $8.29 $47,765 - $114,775
13,845 Added 50.87%
41,060 $259,000
Q1 2023

May 12, 2023

SELL
$2.6 - $8.98 $383,778 - $1.33 Million
-147,607 Reduced 84.43%
27,215 $92,000
Q4 2022

Feb 08, 2023

SELL
$3.67 - $10.06 $613,033 - $1.68 Million
-167,039 Reduced 48.86%
174,822 $1.01 Million
Q3 2022

Nov 10, 2022

BUY
$9.32 - $23.54 $3.18 Million - $8.03 Million
340,968 Added 38182.31%
341,861 $3.21 Million
Q2 2022

Aug 10, 2022

SELL
$21.88 - $57.86 $18,335 - $48,486
-838 Reduced 48.41%
893 $20,000
Q1 2022

May 16, 2022

BUY
$42.67 - $72.15 $5,973 - $10,101
140 Added 8.8%
1,731 $95,000
Q4 2021

Feb 14, 2022

BUY
$62.36 - $92.74 $65,914 - $98,026
1,057 Added 197.94%
1,591 $105,000
Q3 2021

Nov 15, 2021

SELL
$77.81 - $132.88 $59,213 - $101,121
-761 Reduced 58.76%
534 $45,000
Q2 2021

Aug 13, 2021

SELL
$88.36 - $141.98 $81,026 - $130,195
-917 Reduced 41.46%
1,295 $164,000
Q1 2021

May 12, 2021

BUY
$109.42 - $157.18 $22,649 - $32,536
207 Added 10.32%
2,212 $242,000
Q4 2020

Feb 11, 2021

SELL
$71.51 - $146.08 $155,748 - $318,162
-2,178 Reduced 52.07%
2,005 $286,000
Q3 2020

Nov 12, 2020

SELL
$64.25 - $85.72 $118,412 - $157,981
-1,843 Reduced 30.58%
4,183 $296,000
Q2 2020

Jul 31, 2020

BUY
$29.72 - $81.28 $171,543 - $469,148
5,772 Added 2272.44%
6,026 $422,000
Q1 2020

May 01, 2020

SELL
$29.49 - $102.99 $164,672 - $575,096
-5,584 Reduced 95.65%
254 $9,000
Q4 2019

Feb 14, 2020

SELL
$33.02 - $64.96 $101,701 - $200,076
-3,080 Reduced 34.54%
5,838 $367,000
Q3 2019

Nov 14, 2019

SELL
$27.19 - $38.31 $62,618 - $88,227
-2,303 Reduced 20.52%
8,918 $299,000
Q2 2019

Aug 14, 2019

BUY
$14.58 - $25.98 $76,151 - $135,693
5,223 Added 87.08%
11,221 $291,000
Q1 2019

May 14, 2019

BUY
$10.85 - $19.24 $27,472 - $48,715
2,532 Added 73.05%
5,998 $99,000
Q4 2018

Feb 14, 2019

SELL
$10.4 - $23.84 $39,052 - $89,519
-3,755 Reduced 52.0%
3,466 $38,000
Q3 2018

Nov 14, 2018

BUY
$17.97 - $27.65 $3,396 - $5,225
189 Added 2.69%
7,221 $181,000
Q2 2018

Aug 14, 2018

BUY
$13.41 - $25.11 $44,802 - $83,892
3,341 Added 90.52%
7,032 $153,000
Q1 2018

May 15, 2018

BUY
$13.37 - $18.82 $49,348 - $69,464
3,691 New
3,691 $54,000

Others Institutions Holding CDLX

About Cardlytics, Inc.


  • Ticker CDLX
  • Exchange NASDAQ
  • Sector Communication Services
  • Industry Advertising Agencies
  • Shares Outstandng 32,893,800
  • Market Cap $127M
  • Description
  • Cardlytics, Inc. operates an advertising platform in the United States and the United Kingdom. It offers Cardlytics platform, a proprietary native bank advertising channel that enables marketers to reach customers through their network of financial institution partners through digital channels, such as online, mobile applications, email, and var...
More about CDLX
Track This Portfolio

Track Ubs Group Ag Portfolio

Follow Ubs Group Ag and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ubs Group Ag, based on Form 13F filings with the SEC.

News

Stay updated on Ubs Group Ag with notifications on news.